Compare Amylx Pharmaceuticals Inc (AMLX) vs Manchester United PLC (MANU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Manchester United PLC — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Manchester United PLC trades at $22.23 (market cap $3.80B). The key difference: Manchester United PLC is the larger of the two by market cap, and Manchester United PLC pays a 1.26% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | MANU | |
|---|---|---|
Market Cap | $2.64B | $3.80B |
Sector | Health | Media |
52-Week High | $24.19 | $23.53 |
52-Week Low | $7.82 | $15.10 |
Enterprise Value | $2.39B | $4.74B |
Dividend Yield | — | 1.26% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Manchester United PLC
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →
